Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
160.26B
Market cap160.26B
Price-Earnings ratio
34.84
Price-Earnings ratio34.84
Dividend yield
6.54%
Dividend yield6.54%
Average volume
45.41M
Average volume45.41M
High today
$26.95
High today$26.95
Low today
$26.36
Low today$26.36
Open price
$26.49
Open price$26.49
Volume
27.21M
Volume27.21M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$23.58
52 Week low$23.58

Stock Snapshot

The current Pfizer(PFE) stock price is $26.75, with a market capitalization of 160.26B. The stock trades at a price-to-earnings (P/E) ratio of 34.84 and offers a dividend yield of 6.54%.

On 2026-08-13, Pfizer(PFE) stock traded between a low of $26.36 and a high of $26.95. Shares are currently priced at $26.75, which is +1.5% above the low and -0.7% below the high.

The Pfizer(PFE)'s current trading volume is 27.21M, compared to an average daily volume of 45.41M.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

During the past year, Pfizer(PFE) stock moved between $23.58 at its lowest and $28.75 at its peak.

PFE News

Simply Wall St 10h
Pfizer Could Be 10% Undervalued Following Raised Revenue Guidance

Pfizer (PFE) is back in focus after its second quarter results came in ahead of internal expectations, prompting the company to lift full year revenue guidance...

Pfizer Could Be 10% Undervalued Following Raised Revenue Guidance
Benzinga 17h
China Surpasses US in Drug Trials as Washington Responds - Pfizer, Merck & Co - Benzinga

...

China Surpasses US in Drug Trials as Washington Responds - Pfizer, Merck & Co - Benzinga
Simply Wall St 2d
Pfizer Agrees To $44 Million Class Action Settlement

Pfizer (NYSE:PFE) agreed to a US$44 million class action settlement related to its Chantix smoking cessation drug. The settlement addresses allegations that Ch...

Pfizer Agrees To $44 Million Class Action Settlement

Analyst ratings

62%

of 29 ratings
Buy
31%
Hold
62.1%
Sell
6.9%

More PFE News

Nasdaq 2d
Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock

Key Points Pfizer still relies somewhat heavily on Eliquis, a medicine that will lose patent exclusivity relatively soon. The company is working on several pr...

Pfizer Just Raised Its 2026 Guidance -- but the Boost Leans Heavily on a Drug Running Out the Patent Clock
The Motley Fool 2d
Arvinas Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Tuesday, Aug. 4, 2026 at 8 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Randy Teel Chief Scientific Officer...

Arvinas Q2 2026 Earnings Call Transcript
The Motley Fool 2d
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?

AbbVie (ABBV +0.24%) and Pfizer (PFE -1.87%) are two top healthcare stocks that pay above-average dividends. Both may be compelling options for investors to con...

Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
Simply Wall St 5d
Pfizer Stock Leads 3 AI Healthcare Picks Built For Smarter Care

Global energy prices now respond quickly to geopolitical events, which keeps pressure on healthcare systems to do more with constrained budgets and staff. That...

Pfizer Stock Leads 3 AI Healthcare Picks Built For Smarter Care
TipRanks 6d
Pfizer and BioNTech Advance Variant-Adapted COVID-19 Booster in New Phase 4 Study

Pfizer Inc (PFE), Biontech Se Sponsored Adr (BNTX) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium t...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.